Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 682.30x is 133% above its 5-year average of -2080.35x, near the high end of its 5-year range (-6879.92x–3556.99x).
As of the fiscal period ended Sunday, June 30, 2024. 131.28% above its 12-month average of 295.02x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2024 (2024-06-30): 682.30x.
INTEREST COVERAGE RATIO
682.30x
INTEREST COVERAGE RATIO AVG TTM
295.02x
INTEREST COVERAGE RATIO AVG 3Y
-2080.49x
INTEREST COVERAGE RATIO AVG 5Y
-2080.35x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+131.28%
CURRENT VS 3Y AVG
+132.80%
CURRENT VS 5Y AVG
+132.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
+11884.11%
vs the sector median at left
Connect Biopharma Holdings Limited
Market Cap
$60.05M
Interest Coverage Ratio
682.30x
TTM Avg
295.02x
3Y Avg
-2080.49x
5Y Avg
-2080.35x
Market Cap
$60.49M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$59.91M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.11M
Interest Coverage Ratio
-3392.06x
TTM Avg
18.65x
3Y Avg
15.79x
5Y Avg
19.13x
Market Cap
$61.12M
Interest Coverage Ratio
-31.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.99M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.24M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$57.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$63.16M
Interest Coverage Ratio
-58.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $60.05M | 682.30x | 295.02x | -2080.49x | -2080.35x |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.49M | N/A | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.91M | N/A | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $60.11M | -3392.06x | 18.65x | 15.79x | 19.13x |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.12M | -31.98x | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.99M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $58.24M | N/A | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $57.42M | N/A | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | -58.65x | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $63.23M | -66.90x | N/A | N/A | N/A |
Interest Coverage
682.3x
Debt/Equity
0.02
Current Ratio
2.37
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-06-30 | 682.30x |
| 2023-12-31 | 3556.99x |
| 2023-06-30 | -3354.24x |
| 2022-12-31 | -4407.57x |
| 2022-06-30 | -6879.92x |
| 2019-12-31 | -2080.02x |
| 2019-06-30 | -2080.02x |
